CHOLIB

This brand name is authorized in Austria, Cyprus, Estonia, Hong Kong, Ireland, Lithuania, Poland, Singapore, United Kingdom

Active ingredients

The drug CHOLIB contains a combination of these active pharmaceutical ingredients (APIs):

1 Fenofibrate
UNII U202363UOS - FENOFIBRATE

Fenofibrate is a fibric acid derivative whose lipid modifying effects reported in humans are mediated via activation of Peroxisome Proliferator Activated Receptor type α (PPARα). Through activation of PPARα, fenofibrate increases lipolysis and elimination of atherogenic triglyceride rich particles from plasma by activating lipoprotein lipase and reducing production of Apoprotein C-III.

Read about Fenofibrate
2 Simvastatin
UNII AGG2FN16EV - SIMVASTATIN

Simvastatin has a potent activity in inhibiting HMG-CoA reductase (3-hydroxy–3-ethylglutaryl-CoA-reductase). Simvastatin has been shown to reduce both normal and elevated LDL-C concentrations.

Read about Simvastatin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
CHOLIB Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C10BA04 Simvastatin and fenofibrate C Cardiovascular system → C10 Lipid modifying agents → C10B Lipid modifying agents, combinations → C10BA Combinations of various lipid modifying agents
Discover more medicines within C10BA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1624047, 1624058, 1624069, 1624070, 1676000, 1676011
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 321701, 321711
Country: HK Department of Health Drug Office Identifier(s): 66374, 66375
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1071169, 1071170, 1071171, 1071172, 1075159, 1075160
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100302695, 100302703
Country: SG Health Sciences Authority Identifier(s): 15664P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.